Rucha Patil: Honored to Speak at AIIMS Nagpur ToT Workshop on Non-Factor Therapy in Hemophilia A
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared on LinkedIn:
“Honored to be invited as a speaker at the Training of Trainers (ToT) Workshop on Strengthening Integrated Haemoglobinopathy Care and Patient Management, held on 27th-28th March 2026 at AlIMS Nagpur.
I had the opportunity to speak on ‘Cost-effectiveness of Non-Factor Therapy in Hemophilia A in the Indian Context’, an area that is rapidly evolving and holds significant promise for improving accessibility and long-term outcomes in resource-constrained settings.
Engaging discussions, knowledge exchange, and collaborative spirit among clinicians, researchers, and healthcare professionals, all working towards strengthening comprehensive care in haemoglobinopathies and bleeding disorders.
Looking forward to continued efforts in making advanced therapies more accessible and sustainable for patients across India.”
Stay updated with Hemostasis Today.
-
Oct 7, 2026, 04:09James P. Crowley: Could the Microbiome Protect Us From Severe EBV Infection?
-
Oct 7, 2026, 03:58Sohanur Rohanman Sohan: Explainable AI for Anemia Prediction Using Machine Learning
-
Oct 7, 2026, 03:00Sandeep Kumar: A Second Chance for a Child with Fanconi Anemia
-
Oct 7, 2026, 02:41Kemal Karaagac: Optimising DOAC Resumption After Major Bleeding in Atrial Fibrillation
-
Oct 7, 2026, 02:21Joseph Aslan: mPTP Inhibition Targets Platelet Procoagulant Activity and Thrombosis
-
Oct 7, 2026, 02:07Manuel Monreal: ECG Improves Risk Stratification in Acute Pulmonary Embolism
-
Oct 6, 2026, 22:43Alessandra Bosch: Pediatric GTH Opens with Regional Experts Convening on Pediatric Hemostasis and Thrombosis
-
Oct 6, 2026, 22:39Managing Thrombotic Risk in Pregnancy – How the Lab May Help – Sysmex Europe
-
Oct 6, 2026, 22:33Ahmet Davut Aksu: A Multi-Objective Approach to Enhance Fibrinolysis, Selectivity, and Inhibition Resistance